- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02512614
Evaluation of Novel Antimicrobial Hand Towels
July 29, 2015 updated by: Centers for Disease Control and Prevention
In March 2012, the investigators initiated a prospective, cluster-randomized, controlled field trial in Kisumu County, located in an area in western Kenya which has the highest under-five mortality rate in Kenya with 149 childhood deaths per 1,000 live births 9.
The study was designed to evaluate the effectiveness of an antimicrobial hand towel (hereafter referred to as towel) in preventing diarrheal diseases, acute respiratory infections, self-reported fever, and skin infections in children <2 years old.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
In March 2012, the investigators initiated a prospective, cluster-randomized, controlled field trial in Kisumu County, located in an area in western Kenya which has the highest under-five mortality rate in Kenya with 149 childhood deaths per 1,000 live births 9.
The study was designed to evaluate the effectiveness of an antimicrobial hand towel (hereafter referred to as towel) in preventing diarrheal diseases, acute respiratory infections (ARIs), self-reported fever, and skin infections in children <2 years old.
Study Type
Interventional
Enrollment (Actual)
449
Phase
- Phase 2
- Phase 3
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Mother of a child <2 years old
Exclusion Criteria:
- Inaccessible enumeration area in the rainy season
- Multiple eligible children in a single compound
- Moved between census and round 1
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Comparison
Hand hygiene education.
|
|
Experimental: Intervention
Hand hygiene education and 4 antimicrobial hand towels
|
Novel antimicrobial hand towel.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with diarrheal disease
Time Frame: Within 48 hours of enrollment
|
The number of participants that experience 3 or more loose or watery stools
|
Within 48 hours of enrollment
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of participants with respiratory infections
Time Frame: Within 48 hours of enrollment
|
Within 48 hours of enrollment
|
Number of participants with a subjective fever
Time Frame: Within 48 hours of enrollment
|
Within 48 hours of enrollment
|
Number of participants with a skin infection
Time Frame: Within 48 hours of enrollment
|
Within 48 hours of enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2012
Primary Completion (Actual)
April 1, 2013
Study Completion (Actual)
April 1, 2013
Study Registration Dates
First Submitted
June 24, 2015
First Submitted That Met QC Criteria
July 29, 2015
First Posted (Estimate)
July 31, 2015
Study Record Updates
Last Update Posted (Estimate)
July 31, 2015
Last Update Submitted That Met QC Criteria
July 29, 2015
Last Verified
July 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CDC-NCEZID-6102
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fever
-
Meir Medical CenterCompleted
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedYellow Fever | Dengue | Dengue Fever | Dengue Hemorrhagic FeverUnited States
-
The Scientific and Technological Research Council...MonitorCROCompleted
-
Tongji HospitalRecruitingHFRS (Hemorrhagic Fever With Renal Syndrome)China
-
U.S. Army Medical Research and Development CommandBausch Health Americas, Inc.WithdrawnCrimean-Congo Hemorrhagic Fever | Lassa FeverGermany
-
Sanofi Pasteur, a Sanofi CompanyUnited States Department of DefenseCompletedDengue | Dengue Fever | Dengue Hemorrhagic FeverUnited States
-
Carina Mari ApariciWithdrawnFever of Unknown OriginUnited States
-
University Hospital, GrenobleCompletedFever of Unknown OriginFrance
-
Tongji HospitalUnknownFever of Unknown OriginChina
Clinical Trials on Antimicrobial Hand Towel
-
Chang Gung Memorial HospitalCompleted
-
University of ConnecticutNeuroRescue Inc.Completed
-
University of ConnecticutBHSAICompletedHyperthermiaUnited States
-
Lokman Hekim ÜniversitesiMuğla Sıtkı Koçman UniversityCompletedBalance; Distorted | Foot Injuries and DisordersTurkey
-
Duke UniversityThe John A. Hartford FoundationCompleted
-
University of TennesseeKinetic Concepts, Inc.Completed
-
Rochal Industries LLCThe University of Texas Health Science Center at San Antonio; Brooke Army Medical... and other collaboratorsNot yet recruiting
-
Fundación Pública Andaluza para la gestión de la...Completed
-
The Arthritis Research Institute of AmericaCompletedOsteoarthritisUnited States
-
Mayo ClinicCompleted